Drugmakers such as Merck and Actelion Ltd. have been working on drugs for other issues (Merck's an experimental treatment for facial flushing, Actelion's an allergy compound) that also block the D2 protein. Both are in late-stage studies.
Men may be able to regrow all their hair if the inhibiting protein is removed, said George Cotsarelis, chairman of dermatology at the University of Pennsylvania's Perelman School of Medicine in Philadelphia.
Cotsarelis notes that stem cells that create hair still exist in bald men.
The follicles are also there, though they look smaller and produce thinner, shorter hair. Over time, the hair is so short it no longer passes the surface of the skin.
But neither Merck nor Actelion are currently testing their drugs as a cure for hair loss, yet. Interestingly, the role prostaglandin proteins play in hair growth was first suggested by Latisse, a drug developed for glaucoma that doctors discovered could make eyelashes grow super long. Latisse is an artificial version of a prostaglandin protein.
Friday Quick Hits:
- A new study supports previous research showing obesity and belly fat can speed cognitive decline in aging adults. Another study released this week showed hospitalization increased older patients' rate of cognitive decline.
- A bill passed in the U.S. House yesterday would abolish a Medicare cost control board created by the health care law. The Congressional Budget Office has said that getting rid of the board would actually increase Medicare spending by $3 billion from 2018 through 2022.
- And Vice President Joe Biden is visiting a retirement village in Florida today to talk about Medicare and Social Security. "There's no question that the aging of the Baby Boomers puts new pressures on Medicare and Social Security," Biden plans to say, according to USA Today. "The question is: are we going to strengthen and sustain these programs, now and for the future?"
Photo: Steve McAlister/Getty Images